Synopsys Inc (SNPS) 59.14 $SNPS Synopsys Replenishes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Synopsys Inc (SNPS) 59.14 $SNPS

Synopsys Replenishes Repurchase Authorization to $500 Million
PR Newswire - Thu Sep 01, 3:05PM CDT
Synopsys, Inc. (Nasdaq: SNPS) today announced that its Board of Directors has replenished its existing stock repurchase authorization back to $500 million.
SNPS: 59.14 (-0.15)

Synopsys Shares Up 36.4% Since SmarTrend's Buy Recommendation (SNPS)
Comtex SmarTrend(R) - Wed Aug 31, 12:35AM CDT
SmarTrend identified an Uptrend for Synopsys (NASDAQ:SNPS) on February 17th, 2016 at $43.32. In approximately 7 months, Synopsys has returned 36.40% as of today's recent price of $59.08.
SNPS: 59.14 (-0.15)

Synopsys Announces Results of Robert S. Hilbert Memorial Optical Design Competition
PR Newswire - Thu Aug 25, 8:05AM CDT
Synopsys, Inc. (Nasdaq: SNPS) today announced that students from the University of Rochester, University of Saskatchewan, University of Southern California and the University of Arizona received awards for their entries in the 2016 Robert S. Hilbert Memorial Optical Design Competition. The annual competition is open to students in North America working toward a bachelor's, master's or doctorate degree who utilize Synopsys' CODE V® or LightTools® software to perform optical design and engineering research. The awards are granted to students who have submitted papers that demonstrate optical design excellence.
SNPS: 59.14 (-0.15)

Synopsys (SNPS) Touches 52-Week High: Should You Hold?
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 9:30AM CDT
Shares of Synopsys Inc. (SNPS) hit a new 52-week high of $59.04 on Aug 23, 2016, eventually closing at $58.93.
MENT: 24.29 (+0.28), FB: 126.17 (+0.05), CDNS: 25.51 (+0.07), SNPS: 59.14 (-0.15)

Gridbee Achieves First-Pass Silicon Success with Synopsys' DesignWare ARC Processor
PR Newswire - Wed Aug 24, 8:05AM CDT
Highlights:
SNPS: 59.14 (-0.15)

Shares of SNPS Up 36.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Aug 23, 1:04PM CDT
SmarTrend identified an Uptrend for Synopsys (NASDAQ:SNPS) on February 17th, 2016 at $43.32. In approximately 6 months, Synopsys has returned 36.05% as of today's recent price of $58.93.
SNPS: 59.14 (-0.15)

Ride Nasdaq's 8-Week Rally with These 4 Tech Stocks
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:34AM CDT
With Nasdaq logging its longest weekly winning streak in six years, it is time to invest in attractive tech stocks.
AMZN: 770.62 (+1.46), FB: 126.17 (+0.05), STX: 33.71 (-0.03), GOOGL: 791.40 (+1.55), SNPS: 59.14 (-0.15), NTAP: 34.93 (+0.34), MSFT: 57.59 (+0.13), CSCO: 31.58 (+0.14), NVDA: 63.15 (+1.81)

Look for Shares of Synopsys to Potentially Pullback after Yesterday's 4.53% Rise
Comtex SmarTrend(R) - Thu Aug 18, 1:15PM CDT
Synopsys (NASDAQ:SNPS) traded in a range yesterday that spanned from a low of $57.15 to a high of $58.47. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $56.29 on volume of 812,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SNPS: 59.14 (-0.15)

Synopsys (SNPS) Q3 Earnings & Revenues Top; View Strong
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 9:48AM CDT
Synopsys Inc. (SNPS) posted better-than-expected third quarter of fiscal 2016 results.
MENT: 24.29 (+0.28), FB: 126.17 (+0.05), CDNS: 25.51 (+0.07), SNPS: 59.14 (-0.15)

Symantec (SYMC) Touches 52-Week High: Should You Hold?
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 8:17AM CDT
Shares of Symantec Corporation (SYMC) hit a new 52-week high of $22.97 on Aug 15, eventually closing at $22.88.
SNPS: 59.14 (-0.15), INTC: 36.02 (+0.13), MSFT: 57.59 (+0.13), SYMC: 24.15 (+0.02)

29.4% Return Seen to Date on SmarTrend Synopsys Call (SNPS)
Comtex SmarTrend(R) - Tue Aug 16, 12:57AM CDT
SmarTrend identified an Uptrend for Synopsys (NASDAQ:SNPS) on February 17th, 2016 at $43.32. In approximately 6 months, Synopsys has returned 29.42% as of today's recent price of $56.06.
SNPS: 59.14 (-0.15)

Synopsys (SNPS) Q3 Earnings: Can the Stock Surprise?
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 2:22PM CDT
Synopsys Inc. (SNPS) is set to report third-quarter fiscal 2016 results on Aug 17.
ADI: 63.06 (+0.50), SNPS: 59.14 (-0.15), BABA: 97.42 (+0.23), SJM: 140.66 (-1.13)

Zacks.com featured highlights: Laboratory Corp. of America Holdings, Synopsys, Intel, VMware and Euronet Worldwide
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:30AM CDT
Zacks.com featured highlights: Laboratory Corp. of America Holdings, Synopsys, Intel, VMware and Euronet Worldwide
VMW: 73.78 (+0.45), LH: 136.13 (-0.80), EEFT: 77.91 (+0.30), SNPS: 59.14 (-0.15), INTC: 36.02 (+0.13)

Synopsys Shares Up 27.3% Since SmarTrend's Buy Recommendation (SNPS)
Comtex SmarTrend(R) - Mon Aug 08, 1:40PM CDT
SmarTrend identified an Uptrend for Synopsys (NASDAQ:SNPS) on February 17th, 2016 at $43.32. In approximately 6 months, Synopsys has returned 27.28% as of today's recent price of $55.13.
SNPS: 59.14 (-0.15)

5 Stocks with Incredible Sales Growth to Buy Now
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:56AM CDT
A careful selection of stocks considering certain factors should help investors to not only build wealth but beat the market as well - Laboratory Corp. of America Holdings (LH), Synopsys Inc. (SNPS), Intel Corporation (INTC) in focus.
VMW: 73.78 (+0.45), LH: 136.13 (-0.80), EEFT: 77.91 (+0.30), SNPS: 59.14 (-0.15), INTC: 36.02 (+0.13)

Synopsys Announces Earnings Release Date for Third Quarter Fiscal Year 2016
PR Newswire - Wed Aug 03, 3:05PM CDT
Synopsys, Inc. (Nasdaq: SNPS) today announced it will report results for the third quarter fiscal year 2016 on Wednesday, Aug. 17, 2016, after the market close.
SNPS: 59.14 (-0.15)

Seagate (STX) Beats Q4 Earnings & Revenues but Down Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 8:59AM CDT
Seagate Technology plc (STX) reported better-than-expected results for the fourth quarter of fiscal 2016 wherein both the top and bottom line surpassed the respective Zacks Consensus Estimate.
STX: 33.71 (-0.03), SNPS: 59.14 (-0.15), WDC: 46.32 (-0.35), ADBE: 102.90 (+0.59)

SYNOPSYS (SNPS) SHAREHOLDER ALERT - Andrews & Springer LLC Is Investigating Synopsys Inc. For Potential Breach of Fiduciary Duty
BusinessWire - Mon Aug 01, 7:09AM CDT
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Synopsys Inc. (NASDAQGS: SNPS) ("Synopsys" or the "Company".
SNPS: 59.14 (-0.15)

Synopsys Up 24.9% Since SmarTrend Uptrend Call (SNPS)
Comtex SmarTrend(R) - Fri Jul 29, 1:44PM CDT
SmarTrend identified an Uptrend for Synopsys (NASDAQ:SNPS) on February 17th, 2016 at $43.32. In approximately 5 months, Synopsys has returned 24.92% as of today's recent price of $54.11.
SNPS: 59.14 (-0.15)

Synopsys' New Model for Infineon's Next Generation TriCore Architecture Accelerates Early Automotive Software Development and Test
PR Newswire - Thu Jul 28, 8:05AM CDT
Highlights:
SNPS: 59.14 (-0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 4

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 4

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
Gun Violence Expo Aims for National Impact in Chicago

Updated Category News Views 5

Converging Minds at the Chicago Gun Violence Expo In a city known for its resilience amid diverse challenges, the National Gun Violence Prevention Expo is stepping into the spotlight. With all eyes on Chicago from September 24 to 26, this isn't just another event—it’s a clarion call for action. Uniting Influential Voices When you've got former NFL stars like Matt...

Continue Reading
Partners International Launches CareerPath for Youth

Updated Category News Views 7

A Fresh Start for Young Careers with CareerPath You remember the time in life when we thought just having a degree meant something? Well, the game’s changed, and now it’s a twisted jungle where young folks struggle to find their footing. Partners International, a name I’m no stranger to—known for their human capital wizardry—seems to have noticed this chaotic...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 4

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 4

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
Handshake Introduces AI Skills Studio at NYSE Event

Updated Category News Views 6

Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...

Continue Reading
Beemo, Choreo Forge AI Partnership for Wealth Management

Updated Category News Views 10

AI's New Role in Wealth Management Just when you think you've seen it all, along comes a partnership that shakes things up. Beemo Automation is teaming up with Choreo, a heavyweight in the tax-focused registered investment adviser world, to infuse some AI prowess where it matters. Choreographing their moves, they're looking to build something that's not just functional...

Continue Reading
2026 Beauty Icon Awards: Honoring Black Beauty Excellence

Updated Category News Views 7

When it comes to honoring legacy and future within the Black beauty industry, the 2026 Beauty Icon Awards seem ready to steal the spotlight. Set to take place on October 10th at Atlanta's Riverside EpiCenter, this gathering is more than just a fancy shindig – it's a tribute to Black beauty's massive influence on culture and commerce. Celebrating Pioneers and Innovators...

Continue Reading
Holland America Overhauls Half Moon Cay Offerings

Updated Category News Views 5

A Fresh Chapter for Half Moon Cay Mark it down, folks—Holland America Line is shaking things up over at RelaxAway, Half Moon Cay. The cruise line, known for its deep roots in premium cruising, is pouring resources into its private island playground to celebrate its 30th anniversary in 2027. And the timing couldn't be more calculated, what with peak cruise season around...

Continue Reading

Top 5 Most Recently Viewed Articles

How Nemolizumab and Lebrikizumab Are Shaping Atopic Dermatitis Care

Updated Category News Views 99

Transformative Changes in Atopic Dermatitis Treatments The field of dermatology, especially in relation to atopic dermatitis (AD), is experiencing significant transformations. Initially dominated by Sanofi/Regeneron's Dupixent, the landscape is evolving with the introduction of new treatments such as LEO Pharma's Adbry and Pfizer's Cibinqo. While Dupixent continues to...

Continue Reading
Roundhill Investments Updates Monthly Distributions for XPAY

Updated Category News Views 527

Overview of Roundhill Investments' ETF Distributions Roundhill Investments, a prominent ETF sponsor known for innovative financial solutions, has recently provided an update regarding its flagship product, the Roundhill S&P 500® Target 20 Managed Distribution ETF (XPAY). Announcing monthly distributions for the upcoming year, the company is setting an ambitious...

Continue Reading
THOR Industries Plans Engaging Investor Conference Participation

Updated Category News Views 259

Engaging Investor Conferences Ahead for THOR Industries THOR Industries, Inc. (NYSE: THO), a leading manufacturer in the recreational vehicle sector, has announced its participation in two important investor conferences. These events will provide an opportunity for management to connect directly with analysts and institutional investors. Key Details of the Upcoming...

Continue Reading
Oxford Partners Launches Healthcare Division with New Leadership

Updated Category News Views 113

Oxford Partners Launches Its Healthcare Division Oxford Partners, a prominent name in tenant and buyer representation, has recently made exciting strides by establishing its Healthcare Division. This initiative is highlighted by the appointment of Nelson Udstuen, who brings a wealth of experience to his new role as President of the Healthcare Division. Nelson Udstuen's...

Continue Reading
Transforming Cancer Diagnostics: The Rise of Fusion Biopsy

Updated Category News Views 297

Understanding the Fusion Biopsy Market Growth The fusion biopsy market is on the verge of significant growth, projected to reach USD 0.91 billion by 2029, with an impressive compound annual growth rate (CAGR) of 7.1%. This growth trajectory can be attributed to several critical factors, most notably the rising incidence of prostate cancer and the increasing awareness...

Continue Reading